Actively Recruiting

Early Phase 1
Age: 18Years - 55Years
All Genders
Healthy Volunteers
NCT07434895

Repeated CBD Administration and Cannabis Outcomes

Led by Hannah Harris · Updated on 2026-05-05

23

Participants Needed

1

Research Sites

191 weeks

Total Duration

On this page

Sponsors

H

Hannah Harris

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This outpatient study examines how cannabidiol (CBD) affects the behavioral and pain-relieving effects of cannabis.

CONDITIONS

Official Title

Repeated CBD Administration and Cannabis Outcomes

Who Can Participate

Age: 18Years - 55Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • English-speaking, literate adults
  • Male or female
  • Between the ages of 18 and 55
  • Body Mass Index from 18.5 to 32.0 kg/m2
  • Not currently seeking treatment for cannabis or drug use
  • Able to provide written informed consent and perform all study procedures
  • If female, a negative pregnancy test and use of effective contraception during study participation
  • Negative urine drug test for drugs of abuse (other than cannabis) prior to every laboratory session
  • Otherwise healthy as determined by medical history, physical exam, vital signs, and laboratory tests
Not Eligible

You will not qualify if you...

  • Physiologic drug dependence on opioids, benzodiazepines, barbiturates, or alcohol requiring medical management
  • Clinically significant acute or chronic medical problems requiring daily medication or ongoing care
  • Current or past major psychiatric disorder limiting study participation
  • Use of cannabis only for medical reasons with no recreational use
  • Unrelenting chronic pain preventing participation (unable to sit for 8 hours)
  • Current use of daily prescription medications that could interfere with the study, including certain enzyme inducers
  • Clinically significant abnormal ECG or laboratory findings
  • History of seizure disorder
  • Significant history of head injuries requiring medical management or with lasting effects
  • Self-report of synthetic cannabis use in the past 30 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Kentucky

Lexington, Kentucky, United States, 40508

Actively Recruiting

Loading map...

Research Team

P

Paul A Nuzzo, M.A.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here